Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Abdul M, Hoosein N (2001) Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells. Anticancer Res 21:2045–2048

pubmed: 11497296

Abdul M, Hoosein N (2002a) Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 186:99–105

pubmed: 12183081

Abdul M, Hoosein N (2002b) Voltage-gated sodium ion channels in prostate cancer: expression and activity. Anticancer Res 22:1727–1730

pubmed: 12168861

Abdul M, Santo A, Hoosein N (2003) Activity of potassium channel-blockers in breast cancer. Anticancer Res 23:3347–3351

pubmed: 12926074

Abdul M, Ramlal S, Hoosein N (2008) Ryanodine receptor expression correlates with tumor grade in breast cancer. Pathol Oncol Res 14:157–160

pubmed: 18431693

Akamatsu K, Shibata MA, Ito Y, Sohma Y, Azuma H, Otsuki Y (2009) Riluzole induces apoptotic cell death in human prostate cancer cells via endoplasmic reticulum stress. Anticancer Res 29:2195–2204

pubmed: 19528481

Alhothali M, Mathew M, Iyer G, Lawrence HR, Yang S, Chellappan S, Padmanabhan J (2019) Fendiline enhances the cytotoxic effects of therapeutic agents on PDAC cells by inhibiting tumor-promoting signaling events: a potential strategy to combat PDAC. Int J Mol Sci 20:2423

pmcid: 6567171

Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA, Friehling M, Holl GM, Patel MK, Sikes RA, Brown ML (2003) Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3. Mol Cancer Ther 2:1149–1154

pubmed: 14617788

Angelucci A, Valentini A, Millimaggi D, Gravina GL, Miano R, Dolo V, Vicentini C, Bologna M, Federici G, Bernardini S (2006) Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways. Anticancer Drugs 17:1141–1150

pubmed: 17075313

Arcangeli A (2005) Expression and role of hERG channels in cancer cells. Novartis Found Symp 266:225–232. discussion 232-4

pubmed: 16050271

Arcangeli A, Becchetti A (2006) Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol 16:631–639

pubmed: 17064899

Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A (2009) Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 16:66–93

pubmed: 19149563

Arimochi H, Morita K (2006) Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 541:17–23

pubmed: 16753142

Arimochi H, Morita K (2008) Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells. Pharmacology 81:164–172

pubmed: 18025841

Artym VV, Petty HR (2002) Molecular proximity of Kv1.3 voltage-gated potassium channels and β 1-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J Gen Physiol 120:29–37

pubmed: 12084773 pmcid: 2311400

Asher V, Warren A, Shaw R, Sowter H, Bali A, Khan R (2011) The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell Int 11:6

pubmed: 21392380 pmcid: 3063814

Babaer D, Amara S, Ivy M, Zhao Y, Lammers PE, Titze JM, Tiriveedhi V (2018) High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx. Oncotarget 9:25193–25205

pubmed: 29861863 pmcid: 5982760

Bao XX, Xie BS, Li Q, Li XP, Wei LH, Wang JL (2012) Nifedipine induced autophagy through Beclin1 and mTOR pathway in endometrial carcinoma cells. Chin Med J (Engl) 125:3120–3126

Baptista-Hon DT, Robertson FM, Robertson GB, Owen SJ, Rogers GW, Lydon EL, Lee NH, Hales TG (2014) Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function. Br J Anaesth 113(Suppl 1):i39–i48

pubmed: 24852501

Batcioglu K, Uyumlu AB, Satilmis B, Yildirim B, Yucel N, Demirtas H, Onkal R, Guzel RM, Djamgoz MB (2012) Oxidative stress in the in vivo DMBA rat model of breast cancer: suppression by a voltage-gated sodium channel inhibitor (RS100642). Basic Clin Pharmacol Toxicol 111:137–141

pubmed: 22429688

Baudino TA (2015) Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol 12:3–20

pubmed: 26033233

Becchetti A (2011) Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am J Physiol Cell Physiol 301:C255–C265

pubmed: 21430288

Benavides-Serrato A, Saunders JT, Holmes B, Nishimura RN, Lichtenstein A, Gera J (2020) Repurposing potential of riluzole as an ITAF inhibitor in mTOR therapy resistant glioblastoma. Int J Mol Sci 21:344

pmcid: 6981868

Bernal-Ramos G, Hernandez-Gallegos E, Vera E, Chavez-Lopez MG, Zuniga-Garcia V, Sanchez-Perez Y, Garrido E, Camacho J (2017) Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether a-go-go-1 potassium channels. Cell Mol Biol (Noisy-le-Grand) 63:11–13

Bertolesi GE, Shi C, Elbaum L, Jollimore C, Rozenberg G, Barnes S, Kelly ME (2002) The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 62:210–219

pubmed: 12130671

Berzingi S, Newman M, Yu H-G (2016) Altering bioelectricity on inhibition of human breast cancer cells. Cancer Cell Int 16:72–72

pubmed: 27688735 pmcid: 5034549

Besson P, Driffort V, Bon E, Gradek F, Chevalier S, Roger S (2015) How do voltage-gated sodium channels enhance migration and invasiveness in cancer cells? Biochim Biophys Acta 1848:2493–2501

pubmed: 25922224

Bhouri W, Boubaker J, Skandrani I, Ghedira K, Chekir Ghedira L (2012) Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells. Cancer Cell Int 12:26–26

pubmed: 22686580 pmcid: 3487787

Bianchi L, Wible B, Arcangeli A, Taglialatela M, Morra F, Castaldo P, Crociani O, Rosati B, Faravelli L, Olivotto M, Wanke E (1998) Herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 58:815–822

pubmed: 9485040

Biber A, Durusu İZ, Özen C (2018) In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma. Turk J Biol 42:414–421

pubmed: 30930625 pmcid: 6438120

Bidaux G, Flourakis M, Thebault S, Zholos A, Beck B, Gkika D, Roudbaraki M, Bonnal JL, Mauroy B, Shuba Y, Skryma R, Prevarskaya N (2007) Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. J Clin Invest 117:1647–1657

pubmed: 17510704 pmcid: 1866249

Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109:180–187

pubmed: 18648226

Bill A, Hall ML, Borawski J, Hodgson C, Jenkins J, Piechon P, Popa O, Rothwell C, Tranter P, Tria S, Wagner T, Whitehead L, Gaither LA (2014) Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics. J Biol Chem 289:11029–11041

pubmed: 24599954 pmcid: 4036244

Blackiston DJ, Mclaughlin KA, Levin M (2009) Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 8:3519–3528

Bolanz KA, Hediger MA, Landowski CP (2008) The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther 7:271–279

pubmed: 18245667

Bomben VC, Sontheimer HW (2008) Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas. Cell Prolif 41:98–121

pubmed: 18211288 pmcid: 2748659

Bomben VC, Sontheimer H (2010) Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. Glia 58:1145–1156

pubmed: 20544850 pmcid: 3685186

Bondarava M, Li T, Endl E, Wehner F (2009) alpha-ENaC is a functional element of the hypertonicity-induced cation channel in HepG2 cells and it mediates proliferation. Pflugers Arch 458:675–687

pubmed: 19241091 pmcid: 2704294

Bong AHL, Monteith GR (2018) Calcium signaling and the therapeutic targeting of cancer cells. Biochim Biophys Acta Mol Cell Res 1865:1786–1794

pubmed: 29842892

Bonito B, Sauter DR, Schwab A, Djamgoz MB, Novak I (2016) KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34. Pflugers Arch 468:1865–1875

pubmed: 27752766

Borrelli F, Pagano E, Romano B, Panzera S, Maiello F, Coppola D, De Petrocellis L, Buono L, Orlando P, Izzo AA (2014) Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis 35:2787–2797

pubmed: 25269802

Bowen CV, Debay D, Ewart HS, Gallant P, Gormley S, Ilenchuk TT, Iqbal U, Lutes T, Martina M, Mealing G, Merkley N, Sperker S, Moreno MJ, Rice C, Syvitski RT, Stewart JM (2013) In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin. PLoS One 8:e58866

pubmed: 23554944 pmcid: 3598914

Brackenbury WJ (2016) Ion channels in cancer. In: Pitt GS (ed) Ion channels in health and disease. Elsevier Inc., Amsterdam

Brackenbury WJ, Chioni AM, Diss JK, Djamgoz MB (2007) The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 101:149–160

pubmed: 16838113

Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, Margolis KL, Qi L, Reding KW, Shields PG, Simon MS, Wactawski-Wende J, Wang A, Womack C, Manson JE (2017) Use of calcium channel blockers and breast cancer risk in the women's health initiative. Cancer Epidemiol Biomarkers Prev 26:1345–1348

pubmed: 28765339 pmcid: 5607775

Brisson L, Gillet L, Calaghan S, Besson P, Le Guennec JY, Roger S, Gore J (2011) Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae. Oncogene 30:2070–2076

pubmed: 21170089

Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M (2013) Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc Natl Acad Sci U S A 110:E1026–E1034

pubmed: 23431153 pmcid: 3600458

Brockschmidt C, Hirner H, Huber N, Eismann T, Hillenbrand A, Giamas G, Radunsky B, Ammerpohl O, Bohm B, Henne-Bruns D, Kalthoff H, Leithauser F, Trauzold A, Knippschild U (2008) Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut 57:799–806

pubmed: 18203806

Buchanan PJ, Mccloskey KD (2016) CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics. Eur Biophys J 45:621–633

pubmed: 27342111 pmcid: 5045480

Bugan I, Kucuk S, Karagoz Z, Fraser SP, Kaya H, Dodson A, Foster CS, Altun S, Djamgoz MBA (2019) Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate. Prostate Cancer Prostatic Dis 22:569–579

pubmed: 30894674

Campbell TM, Main MJ, Fitzgerald EM (2013) Functional expression of the voltage-gated Na(+)-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells. J Cell Sci 126:4939–4949

pubmed: 23986482

Campia I, Sala V, Kopecka J, Leo C, Mitro N, Costamagna C, Caruso D, Pescarmona G, Crepaldi T, Ghigo D, Bosia A, Riganti C (2012) Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes. Biochem J 447:301–311

pubmed: 22845468

Chang YC, Liu CL, Chen MJ, Hsu YW, Chen SN, Lin CH, Chen CM, Yang FM, Hu MC (2014) Local anesthetics induce apoptosis in human breast tumor cells. Anesth Analg 118:116–124

pubmed: 24247230

Chang H-T, Chou C-T, Yu C-C, Tsai J-Y, Sun T-K, Liang W-Z, Lin K-L, Tseng H-W, Kuo C-C, Chen F-A, Kuo D-H, Pan C-C, Ho C-M, Shieh P, Jan C-R (2015) The mechanism of protriptyline-induced Ca2+ movement and non-Ca2+-triggered cell death in PC3 human prostate cancer cells. J Recept Signal Transduct Res 35:429–434

pubmed: 26096164

Chang Y-L, Liu S-T, Wang Y-W, Lin W-S, Huang S-M (2018) Amiodarone promotes cancer cell death through elevated truncated SRSF3 and downregulation of miR-224. Oncotarget 9:13390–13406

pubmed: 29568365 pmcid: 5862586

Chavez-Lopez MG, Zuniga-Garcia V, Hernandez-Gallegos E, Vera E, Chasiquiza-Anchatuna CA, Viteri-Yanez M, Sanchez-Ramos J, Garrido E, Camacho J (2017) The combination astemizole-gefitinib as a potential therapy for human lung cancer. Onco Targets Ther 10:5795–5803

pubmed: 29263676 pmcid: 5724417

Chen Y, Sánchez A, Rubio ME, Kohl T, Pardo LA, Stühmer W (2011) Functional K(v)10.1 channels localize to the inner nuclear membrane. PLoS One 6:e19257

pubmed: 21559285 pmcid: 3086910

Chen D, Song M, Mohamad O, Yu SP (2014) Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. BMC Cancer 14:716

pubmed: 25255962 pmcid: 4190379

Chen B, Zhang C, Wang Z, Chen Y, Xie H, Li S, Liu X, Liu Z, Chen P (2019) Mechanistic insights into Nav1.7-dependent regulation of rat prostate cancer cell invasiveness revealed by toxin probes and proteomic analysis. FEBS J 286:2549–2561

pubmed: 30927332

Cheng Y, Gulbins E, Siemen D (2011) Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel. Cell Physiol Biochem 27:191–200

pubmed: 21471707

Cherubini A, Taddei GL, Crociani O, Paglierani M, Buccoliero AM, Fontana L, Noci I, Borri P, Borrani E, Giachi M, Becchetti A, Rosati B, Wanke E, Olivotto M, Arcangeli A (2000) HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Br J Cancer 83:1722–1729

pubmed: 11104572 pmcid: 2363441

Cherubini A, Hofmann G, Pillozzi S, Guasti L, Crociani O, Cilia E, Di Stefano P, Degani S, Balzi M, Olivotto M, Wanke E, Becchetti A, Defilippi P, Wymore R, Arcangeli A (2005) Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling. Mol Biol Cell 16:2972–2983

pubmed: 15800067 pmcid: 1142440

Chiang EY, Li T, Jeet S, Peng I, Zhang J, Lee WP, Devoss J, Caplazi P, Chen J, Warming S, Hackos DH, Mukund S, Koth CM, Grogan JL (2017) Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun 8:14644

pubmed: 28248292 pmcid: 5337993

Chioni AM, Fraser SP, Pani F, Foran P, Wilkin GP, Diss JK, Djamgoz MB (2005) A novel polyclonal antibody specific for the Na(v)1.5 voltage-gated Na(+) channel ‘neonatal’ splice form. J Neurosci Methods 147:88–98

pubmed: 16111763

Chittajallu R, Chen Y, Wang H, Yuan X, Ghiani CA, Heckman T, Mcbain CJ, Gallo V (2002) Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc Natl Acad Sci U S A 99:2350–2355

pubmed: 11854528 pmcid: 122368

Clare JJ, Tate SN, Nobbs M, Romanos MA (2000) Voltage-gated sodium channels as therapeutic targets. Drug Discov Today 5:506–520

pubmed: 11084387

Conrad DM, Furlong SJ, Doucette CD, West KA, Hoskin DW (2010) The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells. Apoptosis 15:597–607

pubmed: 20094800

Contassot E, Tenan M, Schnüriger V, Pelte MF, Dietrich PY (2004a) Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol Oncol 93:182–188

pubmed: 15047233

Contassot E, Wilmotte R, Tenan M, Belkouch M-C, Schnüriger V, De Tribolet N, Bourkhardt K, Dietrich P-Y (2004b) Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. J Neuropathol Exp Neurol 63:956–963

pubmed: 15453094

Crociani O, Zanieri F, Pillozzi S, Lastraioli E, Stefanini M, Fiore A, Fortunato A, D'amico M, Masselli M, De Lorenzo E, Gasparoli L, Chiu M, Bussolati O, Becchetti A, Arcangeli A (2013) hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer. Sci Rep 3:3308

pubmed: 24270902 pmcid: 3839040

Crociani O, Lastraioli E, Boni L, Pillozzi S, Romoli MR, D'amico M, Stefanini M, Crescioli S, Masi A, Taddei A, Bencini L, Bernini M, Farsi M, Beghelli S, Scarpa A, Messerini L, Tomezzoli A, Vindigni C, Morgagni P, Saragoni L, Giommoni E, Gasperoni S, Di Costanzo F, Roviello F, De Manzoni G, Bechi P, Arcangeli A (2014) hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. Clin Cancer Res 20:1502–1512

pubmed: 24449824

Darvin P, Baeg SJ, Joung YH, Nipin SP, Kang DY, Byun HJ, Park JU, Yang YM (2015) Tannic acid inhibits the Jak2/STAT3 pathway and induces G1/S arrest and mitochondrial apoptosis in YD-38 gingival cancer cells. Int J Oncol 47:1111–1120

pubmed: 26202061

De Guadalupe Chavez-Lopez M, Perez-Carreon JI, Zuniga-Garcia V, Diaz-Chavez J, Herrera LA, Caro-Sanchez CH, Acuna-Macias I, Gariglio P, Hernandez-Gallegos E, Chiliquinga AJ, Camacho J (2015) Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. Tumour Biol 36:6149–6158

pubmed: 25783527

De Marchi U, Sassi N, Fioretti B, Catacuzzeno L, Cereghetti GM, Szabò I, Zoratti M (2009) Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells. Cell Calcium 45:509–516

pubmed: 19406468

De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A 95:8375–8380

pubmed: 9653194 pmcid: 20983

Del Monaco SM, Marino GI, Assef YA, Damiano AE, Kotsias BA (2009) Cell migration in BeWo cells and the role of epithelial sodium channels. J Membr Biol 232:1–13

pubmed: 19911219

Deshane J, Garner CC, Sontheimer H (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278:4135–4144

pubmed: 12454020

Devita VT Jr, Chu E (2008) A history of cancer chemotherapy. Cancer Res 68:8643–8653

pubmed: 18974103

Ding XW, Luo HS, Jin X, Yan JJ, AI YW (2007) Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines. Med Oncol 24:345–350

Djamgoz MB, Onkal R (2013) Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease. Recent Pat Anticancer Drug Discov 8:66–84

pubmed: 23116083

Djamgoz MB, Coombes RC, Schwab A (2014) Ion transport and cancer: from initiation to metastasis. Philos Trans R Soc Lond B Biol Sci 369:20130092

pubmed: 24493741 pmcid: 3917347

Djamgoz MBA, Fraser SP, Brackenbury WJ (2019) In vivo evidence for voltage-gated sodium channel expression in carcinomas and potentiation of metastasis. Cancers (Basel) 11:1675

Dolderer JH, Schuldes H, Bockhorn H, Altmannsberger M, Lambers C, Von Zabern D, Jonas D, Schwegler H, Linke R, Schröder UH (2010) HERG1 gene expression as a specific tumor marker in colorectal tissues. Eur J Surg Oncol 36:72–77

pubmed: 19577877

Dong Y, Furuta T, Sabit H, Kitabayashi T, Jiapaer S, Kobayashi M, Ino Y, Todo T, Teng L, Hirao A, Zhao S-G, Nakada M (2017) Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug. Oncotarget 8:111728–111741

pubmed: 29340087 pmcid: 5762355

Driffort V, Gillet L, Bon E, Marionneau-Lambot S, Oullier T, Joulin V, Collin C, Pages JC, Jourdan ML, Chevalier S, Bougnoux P, Le Guennec JY, Besson P, Roger S (2014) Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization. Mol Cancer 13:264

pubmed: 25496128 pmcid: 4295566

Dubois C, Vanden Abeele F, Lehen’kyi V, Gkika D, Guarmit B, Lepage G, Slomianny C, Borowiec AS, Bidaux G, Benahmed M, Shuba Y, Prevarskaya N (2014) Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. Cancer Cell 26:19–32

pubmed: 24954132

Duranti C, Arcangeli A (2019) Ion channel targeting with antibodies and antibody fragments for cancer diagnosis. Antibodies (Basel) 8:33

Duranti C, Carraresi L, Sette A, Stefanini M, Lottini T, Crescioli S, Crociani O, Iamele L, De Jonge H, Gherardi E, Arcangeli A (2018) Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging. Oncotarget 9:34972–34989

pubmed: 30405887 pmcid: 6201861

Dutta S, Lopez Charcas O, Tanner S, Gradek F, Driffort V, Roger S, Selander K, Velu SE, Brouillette W (2018) Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells. Bioorg Med Chem 26:2428–2436

pubmed: 29673714 pmcid: 5935567

Dziegielewska B, Brautigan DL, Larner JM, Dziegielewski J (2014) T-type Ca2+ channel inhibition induces p53-dependent cell growth arrest and apoptosis through activation of p38-MAPK in colon cancer cells. Mol Cancer Res 12:348–358

pubmed: 24362252

Eil R, Vodnala SK, Clever D, Klebanoff CA, Sukumar M, Pan JH, Palmer DC, Gros A, Yamamoto TN, Patel SJ, Guittard GC, Yu Z, Carbonaro V, Okkenhaug K, Schrump DS, Linehan WM, Roychoudhuri R, Restifo NP (2016) Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 537:539–543

pubmed: 27626381 pmcid: 5204372

Elliott MJ, Jerzak KJ, Cockburn JG, Safikhani Z, Gwynne WD, Hassell JA, Bane A, Silvester J, Thu KL, Haibe-Kains B, Mak TW, Cescon DW (2018) The antiarrhythmic drug, dronedarone, demonstrates cytotoxic effects in breast cancer independent of thyroid hormone receptor alpha 1 (THRalpha1) antagonism. Sci Rep 8:16562

pubmed: 30410118 pmcid: 6224430

Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105:660–664

pubmed: 17006061

Fairhurst C, Watt I, Martin F, Bland M, Brackenbury WJ (2014) Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database. BMJ Open 4:e006604

pubmed: 25398679 pmcid: 4244419

Fairhurst C, Watt I, Martin F, Bland M, Brackenbury WJ (2015) Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study. Sci Rep 5:16758

pubmed: 26577038 pmcid: 4649474

Fairhurst C, Martin F, Watt I, Doran T, Bland M, Brackenbury WJ (2016) Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database. BMJ Open 6:e011661

pubmed: 27601493 pmcid: 5020752

Felippe Goncalves-De-Albuquerque C, Ribeiro Silva A, Ignacio Da Silva C, Caire Castro-Faria-Neto H, Burth P (2017) Na/K pump and beyond: Na/K-ATPase as a modulator of apoptosis and autophagy. Molecules 22:578

pmcid: 6154632

Fernández-Salas E, Suh KS, Speransky VV, Bowers WL, Levy JM, Adams T, Pathak KR, Edwards LE, Hayes DD, Cheng C, Steven AC, Weinberg WC, Yuspa SH (2002) mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol Cell Biol 22:3610–3620

pubmed: 11997498 pmcid: 133822

Fiorio Pla A, Avanzato D, Munaron L, Ambudkar IS (2012) Ion channels and transporters in cancer. 6. Vascularizing the tumor: TRP channels as molecular targets. Am J Physiol Cell Physiol 302:C9-15

pubmed: 21832241

Föhr K, Knippschild U, Herkommer A, Fauler M, Peifer C, Georgieff M, Adolph O (2017) State-dependent block of voltage-gated sodium channels by the casein-kinase 1 inhibitor IC261. Invest New Drugs 35:277–289

pubmed: 28164251

Fraser SP, Grimes JA, Djamgoz MB (2000) Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines. Prostate 44:61–76

pubmed: 10861759

Fraser SP, Grimes JA, Diss JK, Stewart D, Dolly JO, Djamgoz MB (2003a) Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pflugers Arch 446:559–571

pubmed: 12838421

Fraser SP, Salvador V, Manning EA, Mizal J, Altun S, Raza M, Berridge RJ, Djamgoz MB (2003b) Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. J Cell Physiol 195:479–487

pubmed: 12704658

Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H, Yamaci RF, Pani F, Siwy Z, Krasowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyuturk M, Kaya H, Battaloglu E, De Bella MT, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS, Coombes RC, Djamgoz MB (2005) Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 11:5381–5389

pubmed: 16061851

Fu S, Hirte H, Welch S, Ilenchuk TT, Lutes T, Rice C, Fields N, Nemet A, Dugourd D, Piha-Paul S, Subbiah V, Liu L, Gong J, Hong D, Stewart JM (2017) First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Invest New Drugs 35:324–333

pubmed: 28150073 pmcid: 5418314

Fuca G, Galli G, Poggi M, Lo Russo G, Proto C, Imbimbo M, Vitali M, Ganzinelli M, Lanti C, Molino G, Stangoni F, Zilembo N, De Braud F, Garassino MC, Signorelli D (2018) Low baseline serum sodium concentration is associated with poor clinical outcomes in metastatic non-small cell lung cancer patients treated with immunotherapy. Target Oncol 13:795–800

pubmed: 30306460

Gackiere F, Bidaux G, Delcourt P, Van Coppenolle F, Katsogiannou M, Dewailly E, Bavencoffe A, Van Chuoi-Mariot MT, Mauroy B, Prevarskaya N, Mariot P (2008) CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J Biol Chem 283:10162–10173

pubmed: 18230611

Garcia-Ferreiro RE, Kerschensteiner D, Major F, Monje F, Stuhmer W, Pardo LA (2004) Mechanism of block of hEag1 K+ channels by imipramine and astemizole. J Gen Physiol 124:301–317

pubmed: 15365094 pmcid: 2233905

Garcia-Quiroz J, Camacho J (2011) Astemizole: an old anti-histamine as a new promising anti-cancer drug. Anticancer Agents Med Chem 11:307–314

pubmed: 21443504

García-Quiroz J, García-Becerra R, Barrera D, Santos N, Avila E, Ordaz-Rosado D, Rivas-Suárez M, Halhali A, Rodríguez P, Gamboa-Domínguez A, Medina-Franco H, Camacho J, Larrea F, Díaz L (2012) Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy. PLoS One 7:e45063

pubmed: 22984610 pmcid: 3440370

García-Quiroz J, García-Becerra R, Santos-Martínez N, Barrera D, Ordaz-Rosado D, Avila E, Halhali A, Villanueva O, Ibarra-Sánchez MJ, Esparza-López J, Gamboa-Domínguez A, Camacho J, Larrea F, Díaz L (2014) In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors. BMC Cancer 14:745–745

pubmed: 25280486 pmcid: 4194404

Garzon-Muvdi T, Schiapparelli P, Ap Rhys C, Guerrero-Cazares H, Smith C, Kim DH, Kone L, Farber H, Lee DY, An SS, Levchenko A, Quinones-Hinojosa A (2012) Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. PLoS Biol 10:e1001320

pubmed: 22570591 pmcid: 3341330

Gautier M, Trebak M, Fleig A, Vandier C, Ouadid-Ahidouch H (2019) Ca(2+) channels in cancer. Cell Calcium 84:102083

pubmed: 31606459

Gavrilova-Ruch O, Schönherr K, Gessner G, Schönherr R, Klapperstück T, Wohlrab W, Heinemann SH (2002) Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol 188:137–149

pubmed: 12172639

Genova T, Grolez GP, Camillo C, Bernardini M, Bokhobza A, Richard E, Scianna M, Lemonnier L, Valdembri D, Munaron L, Philips MR, Mattot V, Serini G, Prevarskaya N, Gkika D, Pla AF (2017) TRPM8 inhibits endothelial cell migration via a non-channel function by trapping the small GTPase Rap1. J Cell Biol 216:2107–2130

pubmed: 28550110 pmcid: 5496606

George AL Jr (2005) Inherited disorders of voltage-gated sodium channels. J Clin Invest 115:1990–1999

pubmed: 16075039 pmcid: 1180550

Gilbert SM, Gidley Baird A, Glazer S, Barden JA, Glazer A, Teh LC, King J (2017) A phase I clinical trial demonstrates that nfP2X7-targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma. Br J Dermatol 177:117–124

pubmed: 28150889

Gilbert SM, Oliphant CJ, Hassan S, Peille AL, Bronsert P, Falzoni S, Di Virgilio F, Mcnulty S, Lara R (2019) ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival. Oncogene 38:194–208

pubmed: 30087439

Gillet L, Roger S, Besson P, Lecaille F, Gore J, Bougnoux P, Lalmanach G, Le Guennec JY (2009) Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J Biol Chem 284:8680–8691

pubmed: 19176528 pmcid: 2659227

Gillet L, Roger S, Bougnoux P, Le Guennec JY, Besson P (2011) Beneficial effects of omega-3 long-chain fatty acids in breast cancer and cardiovascular diseases: voltage-gated sodium channels as a common feature? Biochimie 93:4–6

pubmed: 20167245

Gómez-Varela D, Zwick-Wallasch E, Knötgen H, Sánchez A, Hettmann T, Ossipov D, Weseloh R, Contreras-Jurado C, Rothe M, Stühmer W, Pardo LA (2007) Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67:7343–7349

pubmed: 17671204

Gould HJ 3rd, Norleans J, Ward TD, Reid C, Paul D (2018) Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps. Oncotarget 9:15606–15615

pubmed: 29643996 pmcid: 5884651

Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, Di Marzo V, Bifulco M (2006) Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res 312:363–373

pubmed: 16343481

Grimaldi-Bensouda L, Klungel O, Kurz X, De Groot MCH, Maciel Afonso AS, De Bruin ML, Reynolds R, Rossignol M (2016) Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open 6

Grimes JA, Djamgoz MBA (1998) Electrophysiological characterization of voltage-gated Na+ current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J Cell Physiol 175:50–58

pubmed: 9491780

Grimes JA, Fraser SP, Stephens GJ, Downing JE, Laniado ME, Foster CS, Abel PD, Djamgoz MB (1995) Differential expression of voltage-activated Na

pubmed: 7649275

Grolez GP, Hammadi M, Barras A, Gordienko D, Slomianny C, Volkel P, ANGRAND PO, Pinault M, Guimaraes C, Potier-Cartereau M, Prevarskaya N, Boukherroub R, Gkika D (2019) Encapsulation of a TRPM8 agonist, WS12, in lipid nanocapsules potentiates PC3 prostate cancer cell migration inhibition through channel activation. Sci Rep 9:7926

pubmed: 31138874 pmcid: 6538610

Guan L, Song Y, Gao J, Gao J, Wang K (2016) Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells. Oncotarget 7:78619–78630

pubmed: 27732935 pmcid: 5346664

Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H (2009) Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 297:C493–C502

pubmed: 19515901

Gururaja Rao S, Patel NJ, Singh H (2020) Intracellular chloride channels: novel biomarkers in diseases. Front Physiol 11:96–96

pubmed: 32116799 pmcid: 7034325

Guzel RM, Ogmen K, Ilieva KM, Fraser SP, Djamgoz MBA (2019) Colorectal cancer invasiveness in vitro: predominant contribution of neonatal Nav1.5 under normoxia and hypoxia. J Cell Physiol 234:6582–6593

pubmed: 30341901

Haas BR, Sontheimer H (2010) Inhibition of the sodium-potassium-chloride cotransporter isoform-1 reduces glioma invasion. Cancer Res 70:5597–5606

pubmed: 20570904 pmcid: 2896443

Haas M, Wang H, Tian J, Xie Z (2002) Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277:18694–18702

pubmed: 11907028

Habela CW, Olsen ML, Sontheimer H (2008) ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells. J Neurosci 28:9205–9217

pubmed: 18784301 pmcid: 2593939

Habela CW, Ernest NJ, Swindall AF, Sontheimer H (2009) Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J Neurophysiol 101:750–757

pubmed: 19036868

Hamtiaux L, Hansoulle L, Dauguet N, Muccioli GG, Gallez B, Lambert DM (2011) Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism. PLoS One 6:e26823

pubmed: 22046372 pmcid: 3203169

Han X, Wang F, Yao W, Xing H, Weng D, Song X, Chen G, Xi L, Zhu T, Zhou J, Xu G, Wang S, Meng L, Iadecola C, Wang G, Ma D (2007) Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis. Apoptosis 12:1837–1846

pubmed: 17624594

Hartung F, Stühmer W, Pardo L (2011) Tumor cell-selective apoptosis induction through targeting of KV 10.1 via bifunctional TRAIL antibody. Mol Cancer 10:109

pubmed: 21899742 pmcid: 3179451

Haux J, Klepp O, Spigset O, Tretli S (2001) Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer 1:11

pubmed: 11532201 pmcid: 48150

He M, Liu S, Gallolu Kankanamalage S, Borromeo MD, Girard L, Gazdar AF, Minna JD, Johnson JE, Cobb MH (2018) The epithelial sodium channel (αENaC) is a downstream therapeutic target of ASCL1 in pulmonary neuroendocrine tumors. Transl Oncol 11:292–299

pubmed: 29413762 pmcid: 5884185

Hegle AP, Marble DD, Wilson GF (2006) A voltage-driven switch for ion-independent signaling by ether-a-go-go K+ channels. Proc Natl Acad Sci U S A 103:2886–2891

pubmed: 16477030 pmcid: 1413768

Holdhoff M, Ye X, Supko JG, Nabors LB, Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, Leal J, Fisher JD, Desideri S, Grossman SA, Wahl RL, Schiff D (2017) Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas. Neuro Oncol 19:845–852

pubmed: 28371832 pmcid: 5464434

Hong S, Bi M, Wang L, Kang Z, Ling L, Zhao C (2015) CLC-3 channels in cancer (review). Oncol Rep 33:507–514

pubmed: 25421907

Honn KV, Onoda JM, Diglio CA, Carufel MM, Taylor JD, Sloane BF (1984) Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine. Clin Exp Metastasis 2:61–72

pubmed: 6543691

Honn KV, Onoda JM, Pampalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA, Sloane BF (1985) Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. Biochem Pharmacol 34:235–241

pubmed: 3966924

Hopkins MM, Feng X, Liu M, Parker LP, Koh DW (2015) Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cells. Int J Oncol 46:2267–2276

pubmed: 25760245 pmcid: 4383028

Huang X, Jan LY (2014) Targeting potassium channels in cancer. J Cell Biol 206:151–162

pubmed: 25049269 pmcid: 4107787

Huang W, Lu C, Wu Y, Ouyang S, Chen Y (2015) T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines. J Exp Clin Cancer Res 34:54–54

pubmed: 25989794 pmcid: 4443536

Huang J, Furuya H, Faouzi M, Zhang Z, Monteilh-Zoller M, Kelly Galbraith Kawabata F, Horgen D, Kawamori T, Penner R, Fleig A (2017) Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice. Cell Commun Signal 15:30

pubmed: 28810912 pmcid: 5558780

Humeau J, Bravo-San Pedro JM, Vitale I, Nuñez L, Villalobos C, Kroemer G, Senovilla L (2018) Calcium signaling and cell cycle: progression or death. Cell Calcium 70:3–15

pubmed: 28801101

Hutchings CJ, Colussi P, Clark T (2019) Ion channels as therapeutic antibody targets. MAbs 11(2):265–296

pubmed: 30526315

Illek B, Fischer H, Machen TE (1992) Intracellular Ca2+ signalling is modulated by K+ channel blockers in colonic epithelial cells (HT-29/B6). Pflugers Arch 422:48–54

pubmed: 1437524

Innamaa A, Jackson L, Asher V, Van Shalkwyk G, Warren A, Hay D, Bali A, Sowter H, Khan R (2013) Expression and prognostic significance of the oncogenic K2P potassium channel KCNK9 (TASK-3) in ovarian carcinoma. Anticancer Res 33:1401–1408

pubmed: 23564779

Isbilen B, Fraser SP, Djamgoz MB (2006) Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells. Int J Biochem Cell Biol 38:2173–2182

pubmed: 16931105

Jang SJ, Choi HW, Choi DL, Cho S, Rim HK, Choi HE, Kim KS, Huang M, Rhim H, Lee KT, Lee JY (2013) In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers. Bioorg Med Chem Lett 23:6656–6662

pubmed: 24220170

Jang SH, Byun JK, Jeon WI, Choi SY, Park J, Lee BH, Yang JE, Park JB, O'grady SM, Kim DY, Ryu PD, Joo SW, Lee SY (2015) Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3. J Biol Chem 290:12547–12557

pubmed: 25829491 pmcid: 4432276

Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33–42

pubmed: 29935387 pmcid: 6019688

Kaddour-Djebbar I, Choudhary V, Lakshmikanthan V, Shirley R, El Gaish M, Al-Shabrawey M, Al-Husein B, Zhong R, Davis M, Dong Z, Bollag WB, Kumar MV (2012) Diltiazem enhances the apoptotic effects of proteasome inhibitors to induce prostate cancer cell death. J Pharmacol Exp Ther 341:646–655

pubmed: 22393247

Kang HB, Rim HK, Park JY, Choi HW, Choi DL, Seo JH, Chung KS, Huh G, Kim J, Choo DJ, Lee KT, Lee JY (2012) In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor. Bioorg Med Chem Lett 22:1198–1201

pubmed: 22177784

Kapoor N, Bartoszewski R, Qadri YJ, Bebok Z, Bubien JK, Fuller CM, Benos DJ (2009) Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration. J Biol Chem 284:24526–24541

pubmed: 19561078 pmcid: 2782044

Karakurt S, Adali O (2016) Tannic acid inhibits proliferation, migration, invasion of prostate cancer and modulates drug metabolizing and antioxidant enzymes. Anticancer Agents Med Chem 16:781–789

pubmed: 26555610

Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G (2012) Anticancer activity of cardiac glycosides: at the frontier between cell-autonomous and immunological effects. Oncoimmunology 1:1640–1642

pubmed: 23264921 pmcid: 3525630

Khajah MA, Mathew PM, Luqmani YA (2018) Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells. PLoS One 13:e0193779

pubmed: 29590154 pmcid: 5874017

Khatun A, Fujimoto M, Kito H, Niwa S, Suzuki T, Ohya S (2016) Down-regulation of Ca 2+-activated K + channel K Ca 1.1 in human breast cancer MDA-MB-453 cells treated with vitamin D receptor agonists. Int J Mol Sci 17:2083

pmcid: 5187883

Khatun A, Shimozawa M, Kito H, Kawaguchi M, Fujimoto M, Ri M, Kajikuri J, Niwa S, Fujii M, Ohya S (2018) Transcriptional repression and protein degradation of the Ca(2+)-activated K(+) channel K(Ca)1.1 by androgen receptor inhibition in human breast cancer cells. Front Physiol 9:312

pubmed: 29713287 pmcid: 5911984

Kim CJ, Cho YG, Jeong SW, Kim YS, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY, Park WS (2004) Altered expression of KCNK9 in colorectal cancers. Apmis 112:588–594

pubmed: 15601307

Kim IY, Kang YJ, Yoon MJ, Kim EH, Kim SU, Kwon TK, Kim IA, Choi KS (2011) Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol 13:267–279

pubmed: 21292685 pmcid: 3064603

Kischel P, Girault A, Rodat-Despoix L, Chamlali M, Radoslavova S, Abou Daya H, Lefebvre T, Foulon A, Rybarczyk P, Hague F, Dhennin-Duthille I, Gautier M, Ouadid-Ahidouch H (2019) Ion channels: new actors playing in chemotherapeutic resistance. Cancers (Basel) 11:376

Klumpp D, Misovic M, Szteyn K, Shumilina E, Rudner J, Huber SM (2016) Targeting TRPM2 channels impairs radiation-induced cell cycle arrest and fosters cell death of T cell leukemia cells in a Bcl-2-dependent manner. Oxid Med Cell Longev 2016:8026702

pubmed: 26839633

Klumpp D, Frank SC, Klumpp L, Sezgin EC, Eckert M, Edalat L, Bastmeyer M, Zips D, Ruth P, Huber SM (2017) TRPM8 is required for survival and radioresistance of glioblastoma cells. Oncotarget 8:95896–95913

pubmed: 29221175 pmcid: 5707069

Kondratska K, Kondratskyi A, Yassine M, Lemonnier L, Lepage G, Morabito A, Skryma R, Prevarskaya N (2014) Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. Biochim Biophys Acta 1843:2263–2269

pubmed: 24583265

Koster AK, Wood CAP, Thomas-Tran R, Chavan TS, Almqvist J, Choi KH, Du Bois J, Maduke M (2018) A selective class of inhibitors for the CLC-Ka chloride ion channel. Proc Natl Acad Sci U S A 115:E4900–E4909

pubmed: 29669921 pmcid: 6003504

Kosztka L, Rusznák Z, Nagy D, Nagy Z, Fodor J, Szucs G, Telek A, Gönczi M, Ruzsnavszky O, Szentandrássy N, Csernoch L (2011) Inhibition of TASK-3 (KCNK9) channel biosynthesis changes cell morphology and decreases both DNA content and mitochondrial function of melanoma cells maintained in cell culture. Melanoma Res 21:308–322

pubmed: 21512417

Kouba S, Braire J, Felix R, Chantome A, Jaffres PA, Lebreton J, Dubreuil D, Pipelier M, Zhang X, Trebak M, Vandier C, Mathe-Allainmat M, Potier-Cartereau M (2020) Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity. Eur J Med Chem 186:111854

pubmed: 31753515

Kovalenko I, Glasauer A, Schöckel L, Sauter DRP, Ehrmann A, Sohler F, Hägebarth A, Novak I, Christian S (2016) Identification of KCa3.1 channel as a novel regulator of oxidative phosphorylation in a subset of pancreatic carcinoma cell lines. PLoS One 11:e0160658

pubmed: 27494181 pmcid: 4975431

Kunzelmann K, Ousingsawat J, Benedetto R, Cabrita I, Schreiber R (2019) Contribution of anoctamins to cell survival and cell death. Cancers (Basel) 11:382

Laezza C, D’alessandro A, Paladino S, Maria Malfitano A, Chiara Proto M, Gazzerro P, Pisanti S, Santoro A, Ciaglia E, Bifulco M (2012) Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. Eur J Cancer 48:3112–3122

pubmed: 22425263

Lang DG, Wang CM, Cooper BR (1993) Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J Pharmacol Exp Ther 266:829–835

pubmed: 8394919

Lansu K, Gentile S (2013) Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program. Cell Death Dis 4:e652

pubmed: 23744352 pmcid: 3698542

Lastraioli E, Guasti L, Crociani O, Polvani S, Hofmann G, Witchel H, Bencini L, Calistri M, Messerini L, Scatizzi M, Moretti R, Wanke E, Olivotto M, Mugnai G, Arcangeli A (2004) herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 64:606–611

pubmed: 14744775

Lastraioli E, Taddei A, Messerini L, Comin CE, Festini M, Giannelli M, Tomezzoli A, Paglierani M, Mugnai G, De Manzoni G, Bechi P, Arcangeli A (2006) hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett’s esophagus. J Cell Physiol 209:398–404

pubmed: 16883575

Laursen M, Yatime L, Nissen P, Fedosova NU (2013) Crystal structure of the high-affinity Na+K+-ATPase-ouabain complex with Mg2+ bound in the cation binding site. Proc Natl Acad Sci U S A 110:10958–10963

pubmed: 23776223 pmcid: 3704003

Leanza L, Henry B, Sassi N, Zoratti M, Chandy KG, Gulbins E, Szabò I (2012) Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med 4:577–593

pubmed: 22496117 pmcid: 3407946

Leanza L, Biasutto L, Manago A, Gulbins E, Zoratti M, Szabò I (2013a) Intracellular ion channels and cancer. Front Physiol 4:227

pubmed: 24027528 pmcid: 3759743

Leanza L, Trentin L, Becker KA, Frezzato F, Zoratti M, Semenzato G, Gulbins E, Szabo I (2013b) Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia 27(8):1782–1785

pubmed: 23426166

Lee JM, Davis FM, Roberts-Thomson SJ, Monteith GR (2011) Ion channels and transporters in cancer. 4. Remodeling of Ca(2+) signaling in tumorigenesis: role of Ca(2+) transport. Am J Physiol Cell Physiol 301:C969–C976

pubmed: 21593447

Lee H-C, Su M-Y, Lo H-C, Wu C-C, Hu J-R, Lo D-M, Chao T-Y, Tsai H-J, Dai M-S (2015) Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2. Oncotarget 6:42976–42987

pubmed: 26515726 pmcid: 4767485

Lee A, Fraser SP, Djamgoz MBA (2019a) Propranolol inhibits neonatal Nav1.5 activity and invasiveness of MDA-MB-231 breast cancer cells: effects of combination with ranolazine. J Cell Physiol 234:23066–23081

pubmed: 31222761

Lee JR, Lee JY, Kim HJ, Hahn MJ, Kang JS, Cho H (2019b) The inhibition of chloride intracellular channel 1 enhances Ca(2+) and reactive oxygen species signaling in A549 human lung cancer cells. Exp Mol Med 51:81

pmcid: 6802611

Lehen’kyi V, Flourakis M, Skryma R, Prevarskaya N (2007) TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 26:7380–7385

pubmed: 17533368

Leithner K, Hirschmugl B, Li Y, Tang B, Papp R, Nagaraj C, Stacher E, Stiegler P, Lindenmann J, Olschewski A, Olschewski H, Hrzenjak A (2016) TASK-1 regulates apoptosis and proliferation in a subset of non-small cell lung cancers. PLoS One 11:e0157453

pubmed: 27294516 pmcid: 4905626

Lemieszek MK, Stepulak A, Sawa-Wejksza K, Czerwonka A, Ikonomidou C, Rzeski W (2018) Riluzole inhibits proliferation, migration and cell cycle progression and induces apoptosis in tumor cells of various origins. Anticancer Agents Med Chem 18:565–572

pubmed: 29493465

Lenkowski PW, Ko SH, Anderson JD, Brown ML, Patel MK (2004) Block of human NaV1.5 sodium channels by novel alpha-hydroxyphenylamide analogues of phenytoin. Eur J Pharm Sci 21:635–644

pubmed: 15066664

Leslie TK, James AD, Zaccagna F, Grist JT, Deen S, Kennerley A, Riemer F, Kaggie JD, Gallagher FA, Gilbert FJ, Brackenbury WJ (2019) Sodium homeostasis in the tumour microenvironment. Biochim Biophys Acta Rev Cancer 1872:188304

pubmed: 31348974 pmcid: 7115894

Li L, Feng R, Xu Q, Zhang F, Liu T, Cao J, Fei S (2017) Expression of the beta3 subunit of Na(+)/K(+)-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3/AKT pathway. Oncotarget 8:84285–84299

pubmed: 29137423 pmcid: 5663595

Li R, Xiao C, Liu H, Huang Y, Dilger JP, Lin J (2018) Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer 18:666–666

pubmed: 29914426 pmcid: 6006780

Li T, Chen L, Zhao H, Wu L, Masters J, Han C, Hirota K, Ma D (2019) Both Bupivacaine and Levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro. J Anesth 33:17–25

pubmed: 30426213

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318:1375–1387

pubmed: 16728591

Lin S-Y, Chang H-H, Lai Y-H, Lin C-H, Chen M-H, Chang G-C, Tsai M-F, Chen JJW (2015) Digoxin suppresses tumor malignancy through inhibiting multiple Src-related signaling pathways in non-small cell lung cancer. PLoS One 10:e0123305

pubmed: 25955608 pmcid: 4425490

Liu J, Zhang D, Li Y, Chen W, Ruan Z, Deng L, Wang L, Tian H, Yiu A, Fan C, Luo H, Liu S, Wang Y, Xiao G, Chen L, Ye W (2013) Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities. J Med Chem 56:5734–5743

pubmed: 23799775

Liu X, Zou J, Su J, Lu Y, Zhang J, Li L, Yin F (2016) Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer. Int J Oncol 48:243–252

pubmed: 26647723

Lo WL, Donermeyer DL, Allen PM (2012) A voltage-gated sodium channel is essential for the positive selection of CD4(+) T cells. Nat Immunol 13:880–887

pubmed: 22842345 pmcid: 3426661

Lu F, Chen H, Zhou C, Liu S, Guo M, Chen P, Zhuang H, Xie D, Wu S (2008) T-type Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation. Cell Calcium 43:49–58

pubmed: 17532042

Lui VC, Lung SS, Pu JK, Hung KN, Leung GK (2010) Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3. Anticancer Res 30:4515–4524

pubmed: 21115901

Luveta J, Parks RM, Heery DM, Cheung K-L, Johnston SJ (2020) Invasive lobular breast cancer as a distinct disease: implications for therapeutic strategy. Oncol Ther 8:1–11

pubmed: 32700069

Ma B, Pan Y, Song Q, Tie L, Zhang Y, Xiao Y, Zhang J, Han J, Xu Y, Xiang Y, Yu H-M, Li X (2011) The effect of topiramate on tumor-related angiogenesis and on the serum proteome of mice bearing Lewis lung carcinoma. Eur J Pharmacol 663:9–16

pubmed: 21596032

Malamas AS, Jin E, Zhang Q, Haaga J, Lu Z-R (2015) Anti-angiogenic effects of bumetanide revealed by DCE-MRI with a biodegradable macromolecular contrast agent in a colon cancer model. Pharm Res 32:3029–3043

pubmed: 25840948 pmcid: 4529353

Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher D, Liu A, Osman M, Guthrie B, Schade-Bijur S, Hablitz DM, Alvarez VL, Gonda MA (2006) Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol 24:3644–3650

pubmed: 16877732

Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M (2010) Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol 9:413–424

pubmed: 20298965

Mao J, Chen L, Xu B, Wang L, Li H, Guo J, Li W, Nie S, Jacob TJ (2008) Suppression of ClC-3 channel expression reduces migration of nasopharyngeal carcinoma cells. Biochem Pharmacol 75:1706–1716

pubmed: 18359479

Mao J, Yuan J, Wang L, Zhang H, Jin X, Zhu J, Li H, Xu B, Chen L (2013) Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current. J Cell Physiol 228:991–1001

pubmed: 23042559

Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N (2002) Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277:10824–10833

pubmed: 11799114

Martin F, Ufodiama C, Watt I, Bland M, Brackenbury WJ (2015) Therapeutic value of voltage-gated sodium channel inhibitors in breast, colorectal and prostate cancer: a systematic review. Front Pharmacol 6:273

pubmed: 26834632 pmcid: 4714608

Martínez R, Stühmer W, Martin S, Schell J, Reichmann A, Rohde V, Pardo L (2015) Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival. BMC Cancer 15:839

pubmed: 26530050 pmcid: 4632660

Matthews H, Ranson M, Kelso MJ (2011) Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty? Int J Cancer 129:2051–2061

pubmed: 21544803

Matulef K, Howery AE, Tan L, Kobertz WR, Du Bois J, Maduke M (2008) Discovery of potent CLC chloride channel inhibitors. ACS Chem Biol 3:419–428

pubmed: 18642799 pmcid: 2556891

Mazzone A, Eisenman ST, Strege PR, Yao Z, Ordog T, Gibbons SJ, Farrugia G (2012) Inhibition of cell proliferation by a selective inhibitor of the Ca(2+)-activated Cl(-) channel, Ano1. Biochem Biophys Res Commun 427:248–253

pubmed: 22995309 pmcid: 3479349

Meléndez TA, Huanosta-Gutiérrez A, Barriga-Montoya C, González-Andrade M, Gómez-Lagunas F (2020) Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone. Pflügers Arch 472:75–87

pubmed: 31897736

Meng Q, Chen X, Sun L, Zhao C, Sui G, Cai L (2011) Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90. Mol Cell Biochem 348:165–171

pubmed: 21082217

Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, Modjtahedi N, Galluzzi L, André F, Zitvogel L, Kepp O, Kroemer G (2012) Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 4:143ra99

pubmed: 22814852

Metts J, Bradley HL, Wang Z, Shah NP, Kapur R, Arbiser JL, Bunting KD (2017) Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells. Sci Rep 7:4447

pubmed: 28667329 pmcid: 5493614

Mohr CJ, Gross D, Sezgin EC, Steudel FA, Ruth P, Huber SM, Lukowski R (2019) K(Ca)3.1 channels confer radioresistance to breast cancer cells. Cancer 11:1285

Moreels L, Bhat C, Voracova M, Peigneur S, Goovaerts H, Maki-Lohiluoma E, Zahed F, Pardo LA, Yli-Kauhaluoma J, Kiuru P, Tytgat J (2017a) Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancer-relevant potassium channel KV10.1. PLoS One 12:e0188811

pubmed: 29220359 pmcid: 5722316

Moreels L, Peigneur S, Galan DT, De Pauw E, Beress L, Waelkens E, Pardo LA, Quinton L, Tytgat J (2017b) APETx4, a novel sea anemone toxin and a modulator of the cancer-relevant potassium channel KV10.1. Mar Drugs 15(9):287

pmcid: 5618426

Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KC, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, Mccombie WR, Wigler MH, Powers S (2003) Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3:297–302

pubmed: 12676587

Mycielska ME, Palmer CP, Brackenbury WJ, Djamgoz MB (2005) Expression of Na

pubmed: 15611019

Nabissi M, Morelli MB, Santoni M, Santoni G (2012) Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34:48–57

pubmed: 23079154

Nagy D, Gönczi M, Dienes B, Szöőr Á, Fodor J, Nagy Z, Tóth A, Fodor T, Bai P, Szücs G, Rusznák Z, Csernoch L (2014) Silencing the KCNK9 potassium channel (TASK-3) gene disturbs mitochondrial function, causes mitochondrial depolarization, and induces apoptosis of human melanoma cells. Arch Dermatol Res 306:885–902

pubmed: 25318378

Nelson M, Millican-Slater R, Forrest LC, Brackenbury WJ (2014) The sodium channel beta1 subunit mediates outgrowth of neurite-like processes on breast cancer cells and promotes tumour growth and metastasis. Int J Cancer 135:2338–2351

pubmed: 24729314 pmcid: 4200311

Nelson M, Yang M, Dowle AA, Thomas JR, Brackenbury WJ (2015) The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Mol Cancer 14:13

pubmed: 25623198 pmcid: 4320839

Neman J, Termini J, Wilczynski S, Vaidehi N, Choy C, Kowolik CM, Li H, Hambrecht AC, Roberts E, Jandial R (2014) Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci U S A 111:984–989

pubmed: 24395782 pmcid: 3903266

Nguyen CH, Huttary N, Atanasov AG, Chatuphonprasert W, Brenner S, Fristiohady A, Hong J, Stadler S, Holzner S, Milovanovic D, Dirsch VM, Kopp B, Saiko P, Krenn L, Jager W, Krupitza G (2017) Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model. Int J Oncol 50:1879–1888

pubmed: 28393180

Nie F, Liang Y, Jiang B, Li X, Xun H, He W, Lau HT, Ma X (2016) Apoptotic effect of tannic acid on fatty acid synthase over-expressed human breast cancer cells. Tumour Biol 37:2137–2143

pubmed: 26349913

Olsen ML, Schade S, Lyons SA, Amaral MD, Sontheimer H (2003) Expression of voltage-gated chloride channels in human glioma cells. J Neurosci 23:5572–5582

pubmed: 12843258 pmcid: 6741216

Olsen CM, Meussen-Elholm ET, Roste LS, Tauboll E (2004) Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7. Mol Cell Endocrinol 213:173–179

pubmed: 15062565

Onganer PU, Djamgoz MB (2005) Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na

pubmed: 16151702

Oosterwijk E, Gillies RJ (2014) Targeting ion transport in cancer. Philos Trans R Soc Lond B Biol Sci 369:20130107

pubmed: 24493755 pmcid: 3917361

Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N (2001) Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Receptors Channels 7:345–356

pubmed: 11697078

Ouadid-Ahidouch H, Ahidouch A, Pardo LA (2016) Kv10.1 K(+) channel: from physiology to cancer. Pflugers Arch 468:751–762

pubmed: 26743871

Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, BUBENDORF L, Kunzelmann K, Schreiber R (2007) Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13:824–831

pubmed: 17289873

Ouwerkerk R, Jacobs M, Macura K, Wolff A, Stearns V, Mezban S, Khouri N, Bluemke D, Bottomley P (2007) Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23 Na MRI. Breast Cancer Res Treat 106:151–160

pubmed: 17260093

Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP (2016) Repurposing drugs in oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience 10:610–610

pubmed: 26823679 pmcid: 4720497

Pardo LA, Stuhmer W (2014) The roles of K(+) channels in cancer. Nat Rev Cancer 14:39–48

pubmed: 24336491

Pardo LA, Del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S, Stuhmer W (1999) Oncogenic potential of EAG K(+) channels. EMBO J 18:5540–5547

pubmed: 10523298 pmcid: 1171622

Park S-H, Chung YM, Ma J, Yang Q, Berek JS, Hu MCT (2016) Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo. Oncotarget 7:42110–42125

pubmed: 27283899 pmcid: 5173120

Parker KA, Glaysher S, Hurren J, Knight LA, Mccormick D, Suovouri A, Amberger-Murphy V, Pilkington GJ, Cree IA (2012) The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures. Anticancer Drugs 23:65–69

pubmed: 21897201

Parks SK, Chiche J, Pouyssegur J (2013) Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 13:611–623

pubmed: 23969692

Pellegrino M, Rizza P, Nigro A, Ceraldi R, Ricci E, Perrotta I, Aquila S, Lanzino M, Ando S, Morelli C, Sisci D (2018) FoxO3a mediates the inhibitory effects of the antiepileptic drug lamotrigine on breast cancer growth. Mol Cancer Res 16:923–934

pubmed: 29523760

Peruzzo R, Szabo I (2019) Contribution of mitochondrial ion channels to chemo-resistance in cancer cells. Cancer 11:761

Peruzzo R, Biasutto L, Szabò I, Leanza L (2016) Impact of intracellular ion channels on cancer development and progression. Eur Biophys J 45:685–707

pubmed: 27289382 pmcid: 5045486

Peters AA, Milevskiy MJ, Lee WC, Curry MC, Smart CE, Saunus JM, Reid L, Da Silva L, Marcial DL, Dray E, Brown MA, Lakhani SR, Roberts-Thomson SJ, Monteith GR (2016) The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin. Sci Rep 6:25505

pubmed: 27148852 pmcid: 4857793

Pillozzi S, Brizzi MF, Balzi M, Crociani O, Cherubini A, Guasti L, Bartolozzi B, Becchetti A, Wanke E, Bernabei PA, Olivotto M, Pegoraro L, Arcangeli A (2002) HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 16:1791–1798

pubmed: 12200695

Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V, Boddi V, Pegoraro L, Becchetti A, Arcangeli A (2007) VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 110:1238–1250

pubmed: 17420287

Pillozzi S, Masselli M, De Lorenzo E, Accordi B, Cilia E, Crociani O, Amedei A, Veltroni M, D'amico M, Basso G, Becchetti A, Campana D, Arcangeli A (2011) Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood 117:902–914

pubmed: 21048156

Pillozzi S, Masselli M, Gasparoli L, D'amico M, Polletta L, Veltroni M, Favre C, Basso G, Becchetti A, Arcangeli A (2016) Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels. Blood Cancer J 6:e423

pubmed: 27176799 pmcid: 4916301

Pillozzi S, D’amico M, Bartoli G, Gasparoli L, Petroni G, Crociani O, Marzo T, Guerriero A, Messori L, Severi M, Udisti R, Wulff H, Chandy KG, Becchetti A, Arcangeli A (2018) The combined activation of K(Ca)3.1 and inhibition of K(v)11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. Br J Cancer 118:200–212

pubmed: 29161243

Pongrakhananon V, Chunhacha P, Chanvorachote P (2013) Ouabain suppresses the migratory behavior of lung cancer cells. PLoS One 8:e68623

pubmed: 23874694 pmcid: 3707866

Popov S, Venetsanou K, Chedrese P, Pinto V, Takemori H, Franco-Cereceda A, Eriksson P, Mochizuki N, Soares-Da-Silva P, Bertorello A (2012) Increases in intracellular sodium activate transcription and gene expression via the salt-inducible kinase 1 network in an atrial myocyte cell line. Am J Physiol Heart Circ Physiol 303:H57–H65

pubmed: 22467310

Post RL, Kume S, Tobin T, Orcutt B, Sen AK (1969) Flexibility of an active center in sodium-plus-potassium adenosine triphosphatase. J Gen Physiol 54:306–326

pubmed: 19873651 pmcid: 2225916

Potier M, Joulin V, Roger S, Besson P, Jourdan ML, Leguennec JY, Bougnoux P, Vandier C (2006) Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther 5:2946–2953

pubmed: 17121942

Poupon L, Lamoine S, Pereira V, Barriere DA, Lolignier S, Giraudet F, Aissouni Y, Meleine M, Prival L, Richard D, Kerckhove N, Authier N, Balayssac D, Eschalier A, Lazdunski M, Busserolles J (2018) Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin. Neuropharmacology 140:43–61

pubmed: 30056126

Prevarskaya N, Skryma R, Shuba Y (2011) Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11:609–618

pubmed: 21779011

Quast SA, Berger A, Buttstädt N, Friebel K, Schönherr R, Eberle J (2012) General Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC. PLoS One 7:e39290

pubmed: 22723988 pmcid: 3377761

Raderer M, Depisch D, Haider K, Kwasny W, Djavanmard M, Scheithauer W (1993) A phase l/ll study of quinidine, a potential multidrug resistance-reversing agent, in combination with pirarubicin in patients with advanced refractory breast cancer. Oncol Res Treat 16:450–453

Rajamanickam S, Panneerdoss S, Gorthi A, Timilsina S, Onyeagucha B, Kovalskyy D, Ivanov D, Hanes MA, Vadlamudi RK, Chen Y, Bishop AJ, Arbiser JL, Rao MK (2016) Inhibition of FoxM1-mediated DNA repair by imipramine blue suppresses breast cancer growth and metastasis. Clin Cancer Res 22:3524–3536

pubmed: 26927663 pmcid: 4947433

Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA (2015) Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiother Oncol 117:308–314

pubmed: 26482599

Rim HK, Cho S, Shin DH, Chung KS, Cho YW, Choi JH, Lee JY, Lee KT (2014) T-type Ca2+ channel blocker, KYS05090 induces autophagy and apoptosis in A549 cells through inhibiting glucose uptake. Molecules 19:9864–9875

pubmed: 25006791 pmcid: 6270691

Roger S, Besson P, Le Guennec JY (2003) Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim Biophys Acta 1616:107–111

pubmed: 14561467

Roger S, Le Guennec J-Y, Besson P (2004) Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastastic breast cancer cell line. Br J Pharmacol 141:610–615

pubmed: 14744811 pmcid: 1574233

Roger S, Jelassi B, Couillin I, Pelegrin P, Besson P, Jiang LH (2015) Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives. Biochim Biophys Acta 1848:2584–2602

pubmed: 25450340

Rojas E, Corchete L, San Segundo L, Martínez-Blanch JF, Codoñer FM, Paíno T, Puig N, García-Sanz R, Mateos MV, Ocio EM, Misiewicz-Krzeminska I, Gutiérrez NC (2017) Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma. Clin Cancer Res 23(21):6602–6615

pubmed: 28790111

Ru Q, Tian X, Pi MS, Chen L, Yue K, Xiong Q, Ma BM, Li CY (2015) Voltage-gated K+ channel blocker quinidine inhibits proliferation and induces apoptosis by regulating expression of microRNAs in human glioma U87MG cells. Int J Oncol 46:833–840

pubmed: 25420507

Sales TT, Resende FF, Chaves NL, Titze-De-Almeida SS, Bao SN, Brettas ML, Titze-De-Almeida R (2016) Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide. Oncol Lett 12:2581–2589

pubmed: 27698831 pmcid: 5038559

Sato K, Ishizuka J, Cooper CW, Chung DH, Tsuchiya T, Uchida T, Rajaraman S, Townsend CM Jr, Thompson JC (1994) Inhibitory effect of calcium channel blockers on growth of pancreatic cancer cells. Pancreas 9:193–202

pubmed: 8190721

Sauter DRP, Novak I, Pedersen SF, Larsen EH, Hoffmann EK (2015) ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Pflugers Arch 467:1495–1508

pubmed: 25163766

Schmeel LC, Schmeel FC, Kim Y, Blaum-Feder S, Endo T, Schmidt-Wolf IG (2015) Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells. Anticancer Res 35:1369–1376

pubmed: 25750287

Schneditz G, Elias JE, Pagano E, Zaeem Cader M, Saveljeva S, Long K, Mukhopadhyay S, Arasteh M, Lawley TD, Dougan G, Bassett A, Karlsen TH, Kaser A, Kaneider NC (2019) GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump. Sci Signal 12(562):eaau9048

pubmed: 30600262 pmcid: 6364804

Schwab A, Fabian A, Hanley PJ, Stock C (2012) Role of ion channels and transporters in cell migration. Physiol Rev 92:1865–1913

pubmed: 23073633

Seo Y, Park J, Kim M, Lee HK, Kim JH, Jeong JH, Namkung W (2015) Inhibition of ANO1/TMEM16A chloride channel by idebenone and its cytotoxicity to cancer cell lines. PLoS One 10:e0133656

pubmed: 26196390 pmcid: 4511415

Seo Y, Ryu K, Park J, Jeon D-K, Jo S, Lee HK, Namkung W (2017) Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells. PLoS One 12:e0174935

pubmed: 28362855 pmcid: 5376326

Seo Y, Kim J, Chang J, Kim SS, Namkung W, Kim I (2018) Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors. Eur J Med Chem 160:245–255

pubmed: 30347323

Seol HS, Lee SE, Song JS, Lee HY, Park S, Kim I, Singh SR, Chang S, Jang SJ (2016) Glutamate release inhibitor, riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production. Cancer Lett 382:157–165

pubmed: 27612558

Sette A, Spadavecchia J, Landoulsi J, Casale S, Haye B, Crociani O, Arcangeli A (2013) Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. J Nanopart Res 15:2111

pubmed: 24348091 pmcid: 3857862

Sezzi ML, De Luca G, Materazzi M, Bellelli L (1985) Effects of a calcium-antagonist (flunarizine) on cancer cell movement and phagocytosis. Anticancer Res 5:265–271

pubmed: 4015040

Shao X-D, Wu K, Hao Z-M, Hong L, Zhang J, Fan D (2005) The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells. Cancer Biol Ther 4:295–301

pubmed: 15846098

Shapovalov G, Ritaine A, Skryma R, Prevarskaya N (2016) Role of TRP ion channels in cancer and tumorigenesis. Semin Immunopathol 38:357–369

pubmed: 26842901

Shen MR, Droogmans G, Eggermont J, Voets T, Ellory JC, Nilius B (2000) Differential expression of volume-regulated anion channels during cell cycle progression of human cervical cancer cells. J Physiol 529(Pt 2):385–394

pubmed: 11101648 pmcid: 2270206

Shen J-J, Zhan Y-C, Li H-Y, Wang Z (2020) Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines. Acta Pharmacol Sin 41:110–118

pubmed: 31515527

Shi XN, Li H, Yao H, Liu X, Li L, Leung KS, Kung HF, Lu D, Wong MH, Lin MC (2015) In silico identification and in vitro and in vivo validation of anti-psychotic drug fluspirilene as a potential CDK2 inhibitor and a candidate anti-cancer drug. PLoS One 10:e0132072

pubmed: 26147897 pmcid: 4493148

Shin DH, Leem DG, Shin JS, Kim JI, Kim KT, Choi SY, Lee MH, Choi JH, Lee KT (2018) Compound K induced apoptosis via endoplasmic reticulum Ca(2+) release through ryanodine receptor in human lung cancer cells. J Ginseng Res 42:165–174

pubmed: 29719463

Siekmann W, Tina E, Von Sydow AK, Gupta A (2019) Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines. Oncol Lett 18:395–401

pubmed: 31497075 pmcid: 6728124

Simon A, Yang M, Marrison JL, James AD, Hunt MJ, O'toole PJ, Kaye PM, Whittington MA, Chawla S, Brackenbury WJ (2020) Metastatic breast cancer cells induce altered microglial morphology and electrical excitability in vivo. J Neuroinflammation 17:87

pubmed: 32192526 pmcid: 7081703

Singh H, Stefani E, Toro L (2012) Intracellular BK(Ca) (iBK(Ca)) channels. J Physiol 590:5937–5947

pubmed: 22930268 pmcid: 3530108

Song Y, Gao J, Guan L, Chen X, Gao J, Wang K (2018) Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling. Cell Death Dis 9:703

pubmed: 29899325 pmcid: 5999606

Sparks RL, Pool TB, Smith NK, Cameron IL (1983) Effects of amiloride on tumor growth and intracellular element content of tumor cells in vivo. Cancer Res 43:73–77

pubmed: 6847785

Speyer CL, Smith JS, Banda M, Devries JA, Mekani T, Gorski DH (2012) Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 132:565–573

pubmed: 21681448

Squecco R, Tani A, Zecchi-Orlandini S, Formigli L, Francini F (2015) Melatonin affects voltage-dependent calcium and potassium currents in MCF-7 cell line cultured either in growth or differentiation medium. Eur J Pharmacol 758:40–52

pubmed: 25843408

Stettner M, Kramer G, Strauss A, Kvitkina T, Ohle S, Kieseier BC, Thelen P (2012) Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. Eur J Cancer Prev 21:55–64

pubmed: 21979296

Su C-K, Chou C-T, Lin K-L, Liang W-Z, Cheng J-S, Chang H-T, Chen IS, Lu T, Kuo C-C, Yu C-C, Shieh P, Kuo D-H, Chen F-A, Jan C-R (2016) Effect of protriptyline on [Ca2+]i and viability in MG63 human osteosarcoma cells. Toxicol Mech Methods 26:580–587

pubmed: 27790936

Sun YH, Gao X, Tang YJ, Xu CL, Wang LH (2006) Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl 27:671–678

pubmed: 16728719

Sun H, Luo L, Lal B, Ma X, Chen L, Hann CL, Fulton AM, Leahy DJ, Laterra J, Li M (2016) A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nat Commun 7:10339

pubmed: 26842342 pmcid: 4742836

Sun X, Wei Q, Cheng J, Bian Y, Tian C, Hu Y, Li H (2017) Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells. Hum Cell 30:216–225

pubmed: 28326487 pmcid: 5486860

Sun R, He X, Jiang X, Tao H (2019) The new role of riluzole in the treatment of pancreatic cancer through the apoptosis and autophagy pathways. J Cell Biochem. https://doi.org/10.1002/jcb.29533

Szabó I, Bock J, Grassmé H, Soddemann M, Wilker B, Lang F, Zoratti M, Gulbins E (2008) Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci U S A 105:14861–14866

pubmed: 18818304 pmcid: 2567458

Szabò I, Soddemann M, Leanza L, Zoratti M, Gulbins E (2011) Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Differ 18:427–438

pubmed: 20885444

Takada M, Fujimoto M, Motomura H, Hosomi K (2016) Inverse association between sodium channel-blocking antiepileptic drug use and cancer: data mining of spontaneous reporting and claims databases. Int J Med Sci 13:48–59

pubmed: 26816494 pmcid: 4716819

Teichmann M, Kretschy N, Kopf S, Jarukamjorn K, Atanasov AG, Viola K, Giessrigl B, Saiko P, Szekeres T, Mikulits W, Dirsch VM, Huttary N, Krieger S, Jager W, Grusch M, Dolznig H, Krupitza G (2014) Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model. Arch Toxicol 88:691–699

pubmed: 24352538

Thebault S, Flourakis M, Vanoverberghe K, Vandermoere F, Roudbaraki M, Lehen’kyi V, Slomianny C, Beck B, Mariot P, Bonnal JL, Mauroy B, Shuba Y, Capiod T, Skryma R, Prevarskaya N (2006) Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res 66:2038–2047

pubmed: 16489003

Thomas D, Gut B, Karsai S, Wimmer AB, Wu K, Wendt-Nordahl G, Zhang W, Kathofer S, Schoels W, Katus HA, Kiehn J, Karle CA (2003) Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen. Naunyn Schmiedebergs Arch Pharmacol 368:41–48

pubmed: 12827215

Thurber AE, Nelson M, Frost CL, Levin M, Brackenbury WJ, Kaplan DL (2017) IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines. Oncotarget 8:42382–42397

pubmed: 28415575 pmcid: 5522074

Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SE, Onoda JM, Taylor JD, Honn KV (1992) Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation. J Cancer Res Clin Oncol 118:425–434

pubmed: 1377695

Turner KL, Honasoge A, Robert SM, Mcferrin MM, Sontheimer H (2014) A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma. Glia 62:971–981

pubmed: 24585442 pmcid: 4006152

Urrego D, Tomczak AP, Zahed F, Stuhmer W, Pardo LA (2014) Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci 369:20130094

pubmed: 24493742 pmcid: 3917348

Uzun S, Altun S, Bugan İ (2017) Anti-metastatic effect of riluzole on Mat-LyLu rat prostate cancer cell line. Ann Oncol 28:x3

Valerie NC, Dziegielewska B, Hosing AS, Augustin E, Gray LS, Brautigan DL, Larner JM, Dziegielewski J (2013) Inhibition of T-type calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells. Biochem Pharmacol 85:888–897

pubmed: 23287412

Van Der Hoeven D, Cho K-J, Ma X, Chigurupati S, Parton RG, Hancock JF (2013) Fendiline inhibits K-ras plasma membrane localization and blocks K-ras signal transmission. Mol Cell Biol 33:237

pubmed: 23129805 pmcid: 3554123

Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y, Hill AP (2012) hERG K(+) channels: structure, function, and clinical significance. Physiol Rev 92:1393–1478

pubmed: 22988594

Vila-Carriles WH, Kovacs GG, Jovov B, Zhou Z-H, Pahwa AK, Colby G, Esimai O, Gillespie GY, Mapstone TB, Markert JM, Fuller CM, Bubien JK, Benos DJ (2006) Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells. J Biol Chem 281:19220–19232

pubmed: 16704974

Vodnala SK, Eil R, Kishton RJ, Sukumar M, Yamamoto TN, Ha NH, Lee PH, Shin M, Patel SJ, Yu Z, Palmer DC, Kruhlak MJ, Liu X, Locasale JW, Huang J, Roychoudhuri R, Finkel T, Klebanoff CA, Restifo NP (2019) T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 363:eaau0135

pubmed: 30923193 pmcid: 8194369

Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ (2008) TREK-1 is a novel molecular target in prostate cancer. Cancer Res 68:1197–1203

pubmed: 18281496

Walker AJ, Card T, Bates TE, Muir K (2011) Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD. Br J Cancer 104:193–197

pubmed: 21081933

Wang H, Zhang Y, Cao L, Han H, Wang J, Yang B, Nattel S, Wang Z (2002) HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62:4843–4848

pubmed: 12208728

Wang GX, Hatton WJ, Wang GL, Zhong J, Yamboliev I, Duan D, Hume JR (2003) Functional effects of novel anti-ClC-3 antibodies on native volume-sensitive osmolyte and anion channels in cardiac and smooth muscle cells. Am J Physiol Heart Circ Physiol 285:H1453–H1463

pubmed: 12816749

Wang J, Xu YQ, Liang YY, Gongora R, Warnock DG, Ma HP (2007) An intermediate-conductance Ca(2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum. Pflugers Arch 454:945–956

pubmed: 17429684

Wang L, Ma W, Zhu L, Ye D, Li Y, Liu S, Li H, Zuo W, Li B, Ye W, Chen L (2012) ClC-3 is a candidate of the channel proteins mediating acid-activated chloride currents in nasopharyngeal carcinoma cells. Am J Physiol Cell Physiol 303:C14–C23

pubmed: 22496242

Wang Y, Yang Z, Meng Z, Cao H, Zhu G, Liu T, Wang X (2013) Knockdown of TRPM8 suppresses cancer malignancy and enhances epirubicin-induced apoptosis in human osteosarcoma cells. Int J Biol Sci 10:90–102

pubmed: 24391455 pmcid: 3879595

Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, Wang J, Qi R, Matzuk AJ, Song X, Madoux F, Hodder P, Chase P, Griffin PR, Zhou S, Liao L, Xu J, O’malley BW (2014) Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res 74:1506–1517

pubmed: 24390736 pmcid: 3947477

Wannous R, Bon E, Gillet L, Chamouton J, Weber G, Brisson L, Gore J, Bougnoux P, Besson P, Roger S, Chevalier S (2015) Suppression of PPARbeta, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities. Pflugers Arch 467:1249–1259

pubmed: 25017107

Watkins S, Sontheimer H (2011) Hydrodynamic cellular volume changes enable glioma cell invasion. J Neurosci 31:17250–17259

pubmed: 22114291 pmcid: 3253353

Weaver AK, Liu X, Sontheimer H (2004) Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 78:224–234

pubmed: 15378515 pmcid: 2561220

Wheler JJ, Janku F, Falchook GS, Jackson TL, Fu S, Naing A, Tsimberidou AM, Moulder SL, Hong DS, Yang H, Piha-Paul SA, Atkins JT, Garcia-Manero G, Kurzrock R (2014) Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers. Cancer Chemother Pharmacol 73:495–501

pubmed: 24435060 pmcid: 4148903

Williams S, Bateman A, O'kelly I (2013) Altered expression of two-pore domain potassium (K2P) channels in cancer. PLoS One 8:e74589

pubmed: 24116006 pmcid: 3792113

Wilson LE, D'aloisio AA, Sandler DP, Taylor JA (2016) Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Res 18:61

pubmed: 27378129 pmcid: 4932734

Wonderlin WF, Woodfork KA, Strobl JS (1995) Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 165:177–185

pubmed: 7559799

Woods N, Trevino J, Coppola D, Chellappan S, Yang S, Padmanabhan J (2015) Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling. Oncotarget 6:35931–35948

pubmed: 26440150 pmcid: 4742152

Wu Y, Gao B, Xiong Q-J, Wang Y-C, Huang D-K, Wu W-N (2017) Acid-sensing ion channels contribute to the effect of extracellular acidosis on proliferation and migration of A549 cells. Tumor Biol 39. https://doi.org/10.1177/1010428317705750

Xia Z, Bergstrand A, Depierre JW, Nassberger L (1999) The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol 13:338–347

pubmed: 10487422

Xie C, Liu G, Liu J, Huang Z, Wang F, Lei X, Wu X, Huang S, Zhong D, Xu X (2012) Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells. Oncol Lett 4:403–407

pubmed: 22970038 pmcid: 3439105

Xie B, Zhao R, Bai B, Wu Y, Xu Y, Lu S, Fang Y, Wang Z, Maswikiti EP, Zhou X, Pan H, Han W (2018) Identification of key tumorigenesis related genes and their microRNAs in colon cancer. Oncol Rep 40:3551–3560

pubmed: 30272358

Xu S, Liu C, Ma Y, Ji HL, Li X (2016) Potential roles of amiloride-sensitive sodium channels in cancer development. Biomed Res Int 2016:2190216

pubmed: 27403419 pmcid: 4926023

Xu G, Fang Z, Clark LH, Sun W, Yin Y, Zhang R, Sullivan SA, Tran AQ, Kong W, Wang J, Zhou C, Bae-Jump VL (2018) Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cells. Am J Transl Res 10:1663–1676

pubmed: 30018708 pmcid: 6038080

Xuan W, Zhao H, Hankin J, Chen L, Yao S, Ma D (2016) Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro. Sci Rep 6:26277–26277

pubmed: 27195613 pmcid: 4872542

Xue H, Wang Y, Maccormack TJ, Lutes T, Rice C, Davey M, Dugourd D, Ilenchuk TT, Stewart JM (2018) Inhibition of transient receptor potential vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model. J Cancer 9:3196–3207

pubmed: 30210643 pmcid: 6134823

Yamaci RF, Fraser SP, Battaloglu E, Kaya H, Erguler K, Foster CS, Djamgoz MBA (2017) Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancer. Pathol Res Pract 213:900–907

pubmed: 28698102

Yamamura H, Ugawa S, Ueda T, Shimada S (2008) Expression analysis of the epithelial Na+ channel delta subunit in human melanoma G-361 cells. Biochem Biophys Res Commun 366:489–492

pubmed: 18073141

Yang M, Brackenbury WJ (2013) Membrane potential and cancer progression. Front Physiol 4:185

pubmed: 23882223 pmcid: 3713347

Yang JL, Friedlander ML (2001) Effect of nifedipine in metastatic colon cancer with DNA mismatch repair gene defect. Lancet 357(9270):1767–1768

pubmed: 11403819

Yang DK, Kim SJ (2017) Desipramine induces apoptosis in hepatocellular carcinoma cells. Oncol Rep 38:1029–1034

pubmed: 28627696

Yang S, Zhang JJ, Huang XY (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15:124–134

pubmed: 19185847

Yang M, Kozminski DJ, Wold LA, Modak R, Calhoun JD, Isom LL, Brackenbury WJ (2012) Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. Breast Cancer Res Treat 134:603–615

pubmed: 22678159 pmcid: 3401508

Yang M, James AD, Suman R, Kasprowicz R, Nelson M, O'toole PJ, Brackenbury WJ (2020) Voltage-dependent activation of Rac1 by Nav 1.5 channels promotes cell migration. J Cell Physiol 235:3950–3972

pubmed: 31612502

Yildirim S, Altun S, Gumushan H, Patel A, Djamgoz MBA (2012) Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo. Cancer Lett 323:58–61

pubmed: 22484465

Yip D, Le MN, Chan JL, Lee JH, Mehnert JA, Yudd A, Kempf J, Shih WJ, Chen S, Goydos JS (2009) A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res 15:3896–3902

pubmed: 19458050 pmcid: 2812866

Yoon JR, Whipple RA, Balzer EM, Cho EH, Matrone MA, Peckham M, Martin SS (2011) Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Res Treat 129:691–701

pubmed: 21069453

Yuan SY, Cheng CL, Ho HC, Wang SS, Chiu KY, Su CK, Ou YC, Lin CC (2015) Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo. Eur J Pharmacol 761:309–320

pubmed: 26086857

Zhang L, Barritt GJ (2004) Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Res 64:8365–8373

pubmed: 15548706

Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO, Semenza GL (2008) Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth. Proc Natl Acad Sci 105:19579–19586

pubmed: 19020076 pmcid: 2604945

Zhang C, Yuan XR, Li HY, Zhao ZJ, Liao YW, Wang XY, Su J, Sang SS, Liu Q (2015) Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway. Cell Physiol Biochem 35:419–432

pubmed: 25613036

Zhang P, Yang X, Yin Q, Yi J, Shen W, Zhao L, Zhu Z, Liu J (2016) Inhibition of SK4 potassium channels suppresses cell proliferation, migration and the epithelial-mesenchymal transition in triple-negative breast cancer cells. PLoS One 11:e0154471

pubmed: 27124117 pmcid: 4849628

Zhang P, Liu X, Li H, Chen Z, Yao X, Jin J, Ma X (2017a) TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKbeta/AMPKalpha/mTOR pathway. Sci Rep 7:3158

pubmed: 28600513 pmcid: 5466655

Zhang Y, Cruickshanks N, Yuan F, Wang B, Pahuski M, Wulfkuhle J, Gallagher I, Koeppel AF, Hatef S, Papanicolas C, Lee J, Bar EE, Schiff D, Turner SD, Petricoin EF, Gray LS, Abounader R (2017b) Targetable T-type calcium channels drive glioblastoma. Cancer Res 77:3479–3490

pubmed: 28512247 pmcid: 5505315

Zhao L, Zhao Y, Schwarz B, Mysliwietz J, Hartig R, Camaj P, Bao Q, Jauch K-W, Guba M, Ellwart JW, Nelson PJ, Bruns CJ (2016) Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells. Int J Oncol 49:99–110

pubmed: 27177126 pmcid: 4902079

Zhong J, Kong X, Zhang H, Yu C, Xu Y, Kang J, Yu H, Yi H, Yang X, Sun L (2012) Inhibition of CLIC4 enhances autophagy and triggers mitochondrial and ER stress-induced apoptosis in human glioma U251 cells under starvation. PLoS One 7:e39378

pubmed: 22761775 pmcid: 3382619

Zhou Z, Song J, Li W, Liu X, Cao L, Wan L, Tan Y, Ji S, Liang Y, Gong F (2017) The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis. J Exp Clin Cancer Res 36(1):130

pubmed: 28927426 pmcid: 5606037

Zhou FM, Huang YY, Tian T, Li XY, Tang YB (2018) Knockdown of chloride channel-3 inhibits breast cancer growth in vitro and in vivo. J Breast Cancer 21:103–111

pubmed: 29963105 pmcid: 6015970

Zhu S, Zhou HY, Deng SC, Deng SJ, He C, Li X, Chen JY, Jin Y, Hu ZL, Wang F, Wang CY, Zhao G (2017) ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca(2+)/RhoA pathway. Cell Death Dis 8:e2806

pubmed: 28518134 pmcid: 5520710

Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Journal

Informations de publication

Résumé

Identifiants

Substances chimiques

Types de publication

Langues

Sous-ensembles de citation

Pagination

Subventions

Informations de copyright

Références

Auteurs

Alina L Capatina (AL)

Dimitris Lagos (D)

William J Brackenbury (WJ)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Smoking Cessation and Incident Cardiovascular Disease.

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Classifications MeSH